| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
35,410,000 |
| Market
Cap: |
14.02(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$197.54 - $413.31 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 463 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s services include medical department, clinical trial management, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, and quality assurance.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,000,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$309,116,534 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
34 |
| Total Shares Sold |
1,742,072 |
2,404,472 |
3,519,952 |
3,608,378 |
| Total Sell Value |
$699,894,249 |
$883,563,199 |
$1,155,800,595 |
$1,175,475,107 |
| Total People Sold |
6 |
6 |
8 |
8 |
| Total Sell Transactions |
39 |
65 |
82 |
89 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Medpace Investors, Llc |
10% Owner |
– – • |
2021-07-20 |
4 |
AS |
$183.06 |
$1,862,819 |
D/D |
(10,176) |
6,127,343 |
|
17% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-07-15 |
4 |
AS |
$181.88 |
$2,491,210 |
D/D |
(13,697) |
6,151,415 |
|
25% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-07-15 |
4 |
AS |
$181.88 |
$2,491,210 |
I/I |
(13,697) |
6,151,415 |
|
25% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-07-14 |
4 |
AS |
$182.63 |
$2,013,678 |
D/D |
(11,026) |
6,165,112 |
|
24% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-07-14 |
4 |
AS |
$182.63 |
$2,013,678 |
I/I |
(11,026) |
6,165,112 |
|
24% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-07-13 |
4 |
AS |
$182.96 |
$2,387,628 |
D/D |
(13,050) |
6,176,138 |
|
24% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-07-13 |
4 |
AS |
$182.96 |
$2,387,628 |
I/I |
(13,050) |
6,176,138 |
|
24% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-07-12 |
4 |
AS |
$183.22 |
$1,931,139 |
D/D |
(10,540) |
6,189,188 |
|
22% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-07-12 |
4 |
AS |
$183.22 |
$1,931,139 |
I/I |
(10,540) |
6,189,188 |
|
22% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-07-09 |
4 |
AS |
$183.34 |
$2,309,534 |
I/I |
(12,597) |
6,199,728 |
|
19% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-07-09 |
4 |
AS |
$183.34 |
$2,309,534 |
D/D |
(12,597) |
6,199,728 |
|
19% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-07-08 |
4 |
AS |
$180.18 |
$711,891 |
I/I |
(3,951) |
6,212,325 |
|
23% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-07-08 |
4 |
AS |
$180.18 |
$711,891 |
D/D |
(3,951) |
6,212,325 |
|
23% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-07-07 |
4 |
AS |
$180.33 |
$824,829 |
I/I |
(4,574) |
6,216,276 |
|
24% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-07-07 |
4 |
AS |
$180.33 |
$824,829 |
D/D |
(4,574) |
6,216,276 |
|
24% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-07-06 |
4 |
AS |
$180.58 |
$853,963 |
I/I |
(4,729) |
6,220,850 |
|
21% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-07-06 |
4 |
AS |
$180.58 |
$853,963 |
D/D |
(4,729) |
6,220,850 |
|
21% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-07-02 |
4 |
AS |
$180.16 |
$640,649 |
D/D |
(3,556) |
6,225,579 |
|
24% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-07-02 |
4 |
AS |
$180.16 |
$640,649 |
I/I |
(3,556) |
6,225,579 |
|
24% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-07-01 |
4 |
AS |
$180.03 |
$42,847 |
D/D |
(238) |
6,229,135 |
|
26% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-07-01 |
4 |
AS |
$180.03 |
$42,847 |
I/I |
(238) |
6,229,135 |
|
26% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-06-29 |
4 |
AS |
$181.11 |
$892,148 |
D/D |
(4,926) |
6,229,373 |
|
28% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-06-29 |
4 |
AS |
$181.11 |
$892,148 |
I/I |
(4,926) |
6,229,373 |
|
28% |
|
| Medpace Investors, Llc |
10% Owner |
– – • |
2021-06-28 |
4 |
AS |
$181.15 |
$1,489,959 |
D/D |
(8,225) |
6,234,299 |
|
24% |
|
| Troendle August J. |
President & CEO |
• • • |
2021-06-28 |
4 |
AS |
$181.15 |
$1,489,959 |
I/I |
(8,225) |
6,234,299 |
|
24% |
|
215 Records found
|
|
Page 7 of 9 |
|
|
6.16 (1.58%) 
